Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies

The COVID-19 pandemic has had an enormous impact on economies and health systems globally, therefore a top priority is the development of increasingly better diagnostic and surveillance alternatives to slow down the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order...

Descripción completa

Guardado en:

Detalles Bibliográficos
Autores principales:	Linda P. Guaman-Bautista, Erick Moreta-Urbano, Claudia G. Oña-Arias, Marbel Torres-Arias, Nikolaos C. Kyriakidis, Koray Malcı, Nestor Jonguitud-Borrego, Leonardo Rios-Solis, Espiridion Ramos-Martinez, Andrés López-Cortés, Carlos Barba-Ostria
Formato:	article
Lenguaje:	EN
Publicado:	MDPI AG 2021
Materias:	COVID-19 nucleic acid amplification test antigen testing CRISPR-based diagnostics nanotechnology-based diagnostics automation Medicine (General) R5-920
Acceso en línea:	https://doaj.org/article/a137758a1a264ff386ea7a23d16f18fc
Etiquetas:	Agregar Etiqueta Sin Etiquetas, Sea el primero en etiquetar este registro!

id	oai:doaj.org-article:a137758a1a264ff386ea7a23d16f18fc
record_format	dspace
spelling	oai:doaj.org-article:a137758a1a264ff386ea7a23d16f18fc2021-11-25T17:20:27ZTracking SARS-CoV-2: Novel Trends and Diagnostic Strategies10.3390/diagnostics111119812075-4418https://doaj.org/article/a137758a1a264ff386ea7a23d16f18fc2021-10-01T00:00:00Zhttps://www.mdpi.com/2075-4418/11/11/1981https://doaj.org/toc/2075-4418The COVID-19 pandemic has had an enormous impact on economies and health systems globally, therefore a top priority is the development of increasingly better diagnostic and surveillance alternatives to slow down the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order to establish massive testing and contact tracing policies, it is crucial to have a clear view of the diagnostic options available and their principal advantages and drawbacks. Although classical molecular methods such as RT-qPCR are broadly used, diagnostic alternatives based on technologies such as LAMP, antigen, serological testing, or the application of novel technologies such as CRISPR-Cas for diagnostics, are also discussed. The present review also discusses the most important automation strategies employed to increase testing capability. Several serological-based diagnostic kits are presented, as well as novel nanotechnology-based diagnostic methods. In summary, this review provides a clear diagnostic landscape of the most relevant tools to track COVID-19.Linda P. Guaman-BautistaErick Moreta-UrbanoClaudia G. Oña-AriasMarbel Torres-AriasNikolaos C. KyriakidisKoray MalcıNestor Jonguitud-BorregoLeonardo Rios-SolisEspiridion Ramos-MartinezAndrés López-CortésCarlos Barba-OstriaMDPI AGarticleCOVID-19nucleic acid amplification testantigen testingCRISPR-based diagnosticsnanotechnology-based diagnosticsautomationMedicine (General)R5-920ENDiagnostics, Vol 11, Iss 1981, p 1981 (2021)
institution	DOAJ
collection	DOAJ
language	EN
topic	COVID-19 nucleic acid amplification test antigen testing CRISPR-based diagnostics nanotechnology-based diagnostics automation Medicine (General) R5-920
spellingShingle	COVID-19 nucleic acid amplification test antigen testing CRISPR-based diagnostics nanotechnology-based diagnostics automation Medicine (General) R5-920 Linda P. Guaman-Bautista Erick Moreta-Urbano Claudia G. Oña-Arias Marbel Torres-Arias Nikolaos C. Kyriakidis Koray Malcı Nestor Jonguitud-Borrego Leonardo Rios-Solis Espiridion Ramos-Martinez Andrés López-Cortés Carlos Barba-Ostria Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
description	The COVID-19 pandemic has had an enormous impact on economies and health systems globally, therefore a top priority is the development of increasingly better diagnostic and surveillance alternatives to slow down the spread of the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2). In order to establish massive testing and contact tracing policies, it is crucial to have a clear view of the diagnostic options available and their principal advantages and drawbacks. Although classical molecular methods such as RT-qPCR are broadly used, diagnostic alternatives based on technologies such as LAMP, antigen, serological testing, or the application of novel technologies such as CRISPR-Cas for diagnostics, are also discussed. The present review also discusses the most important automation strategies employed to increase testing capability. Several serological-based diagnostic kits are presented, as well as novel nanotechnology-based diagnostic methods. In summary, this review provides a clear diagnostic landscape of the most relevant tools to track COVID-19.
format	article
author	Linda P. Guaman-Bautista Erick Moreta-Urbano Claudia G. Oña-Arias Marbel Torres-Arias Nikolaos C. Kyriakidis Koray Malcı Nestor Jonguitud-Borrego Leonardo Rios-Solis Espiridion Ramos-Martinez Andrés López-Cortés Carlos Barba-Ostria
author_facet	Linda P. Guaman-Bautista Erick Moreta-Urbano Claudia G. Oña-Arias Marbel Torres-Arias Nikolaos C. Kyriakidis Koray Malcı Nestor Jonguitud-Borrego Leonardo Rios-Solis Espiridion Ramos-Martinez Andrés López-Cortés Carlos Barba-Ostria
author_sort	Linda P. Guaman-Bautista
title	Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
title_short	Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
title_full	Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
title_fullStr	Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
title_full_unstemmed	Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies
title_sort	tracking sars-cov-2: novel trends and diagnostic strategies
publisher	MDPI AG
publishDate	2021
url	https://doaj.org/article/a137758a1a264ff386ea7a23d16f18fc
work_keys_str_mv	AT lindapguamanbautista trackingsarscov2noveltrendsanddiagnosticstrategies AT erickmoretaurbano trackingsarscov2noveltrendsanddiagnosticstrategies AT claudiagonaarias trackingsarscov2noveltrendsanddiagnosticstrategies AT marbeltorresarias trackingsarscov2noveltrendsanddiagnosticstrategies AT nikolaosckyriakidis trackingsarscov2noveltrendsanddiagnosticstrategies AT koraymalcı trackingsarscov2noveltrendsanddiagnosticstrategies AT nestorjonguitudborrego trackingsarscov2noveltrendsanddiagnosticstrategies AT leonardoriossolis trackingsarscov2noveltrendsanddiagnosticstrategies AT espiridionramosmartinez trackingsarscov2noveltrendsanddiagnosticstrategies AT andreslopezcortes trackingsarscov2noveltrendsanddiagnosticstrategies AT carlosbarbaostria trackingsarscov2noveltrendsanddiagnosticstrategies
_version_	1718412487492108288

Tracking SARS-CoV-2: Novel Trends and Diagnostic Strategies

Ejemplares similares